
New protocol utilizing beta-hydroxybutyrate testing can shorten fasting time for insulinoma diagnosis, reducing costs and improving patient experience.


coremsg

Stopping the fast prior to 72 hours resulted in hospital cost savings for patients with hypoglycemia in whom doctors used a new test to rule out an insulinoma, a rare pancreatic tumor.

New Protocol Cuts Fasting Time to Rule Out Insulinoma

new-protocol-reduces-fasting-time-for-insulinoma-diagnosis


New Protocol Reduces Fasting Time for Insulinoma Diagnosis
